132 related articles for article (PubMed ID: 11399814)
1. Seroprevalence of known and putative hepatitis markers in United States blood donors with ALT levels at least 120 IU per L.
Notari EP; Orton SL; Cable RG; Grindon AJ; Lenes BA; Williams AE; McMillan KM; Trouern-Trend JJ; Wolf-Nugent JS; Xu YL; Dodd RY;
Transfusion; 2001 Jun; 41(6):751-5. PubMed ID: 11399814
[TBL] [Abstract][Full Text] [Related]
2. Infection with hepatitis G virus and its strain variant, the GB agent (GBV-C), among blood donors in Japan.
Yoshikawa A; Fukuda S; Itoh K; Kosaki N; Suzuki T; Hirakawa K; Nakao H; Inoue T; Fukuda M; Okamoto H
Transfusion; 1997 Jun; 37(6):657-63. PubMed ID: 9191829
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus and GB virus C/hepatitis G virus viremia in Swedish blood donors with different alanine aminotransferase levels.
Björkman P; Sundström G; Widell A
Transfusion; 1998 Apr; 38(4):378-84. PubMed ID: 9595021
[TBL] [Abstract][Full Text] [Related]
4. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
Kusendová K; Gavorník P; Sabaka P; Sviteková K
Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
[TBL] [Abstract][Full Text] [Related]
5. GB virus type C/HGV markers in HCV RNA-positive French blood donors: correlation with HCV genotypes and risk factors.
Bouchardeau F; Laperche S; Pillonel J; Elghouzzi MH; Maisonneuve P; Tirtaine C; Boiret E; Razer A; Girault A; Beaulieu MJ; Couroucé AM
Transfusion; 2000 Jul; 40(7):875-8. PubMed ID: 10924619
[TBL] [Abstract][Full Text] [Related]
6. [Alanine aminotransferase (ALAT, GPT): a reevaluation of exclusion limits for blood donors].
Grunenberg R; Banik N; Krüger J
Infusionsther Transfusionsmed; 1995 Jun; 22(3):145-51. PubMed ID: 7640509
[TBL] [Abstract][Full Text] [Related]
7. Correlation of hepatitis C RNA and serum alanine aminotransferase in hepatitis B and C seronegative healthy blood donors.
Ali N; Moiz B; Moatter T; Ahmed S; Adil SN; Khurshid M
Indian J Pathol Microbiol; 2010; 53(3):480-5. PubMed ID: 20699507
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients.
Roth WK; Waschk D; Marx S; Tschauder S; Zeuzem S; Bialleck H; Weber H; Seifried E
Transfusion; 1997 Jun; 37(6):651-6. PubMed ID: 9191828
[TBL] [Abstract][Full Text] [Related]
9. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, persistence and liver enzyme levels of HGV RNA-positive blood donors determined by large-scale screening and transmission by blood components.
Hitzler WE; Runkel S
Clin Lab; 2004; 50(1-2):25-31. PubMed ID: 15000218
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of GB virus type C/hepatitis G virus RNA and anti-E2 among blood donors in Southeastern France.
Cantaloube JF; Gallian P; Biagini P; Attoui H; Escher J; Zappitelli JP; Delord Y; de Micco P; de Lamballerie X
Transfusion; 1999 Jan; 39(1):95-102. PubMed ID: 9920172
[TBL] [Abstract][Full Text] [Related]
12. Limited utility of alanine aminotransferase screening of hepatitis C antibody-screened blood donors.
Cable R; Badon S; Pray C; Popovsky MA
Transfusion; 1997 Feb; 37(2):206-10. PubMed ID: 9051097
[TBL] [Abstract][Full Text] [Related]
13. High rate of GB virus type C/HGV transmission from mother to infant: possible implications for the prevalence of infection in blood donors.
Lefrère JJ; Sender A; Mercier B; Mariotti M; Pernot F; Soulié JC; Malvoisin A; Berry M; Gabai A; Lattes F; Galiay JC; Pawlak C; de Lachaux V; Chauveau V; Hreiche G; Larsen M; Férec C; Parnet-Mathieu F; Roudot-Thoraval F; Brossard Y
Transfusion; 2000 May; 40(5):602-7. PubMed ID: 10827267
[TBL] [Abstract][Full Text] [Related]
14. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study.
Busch MP; Korelitz JJ; Kleinman SH; Lee SR; AuBuchon JP; Schreiber GB
Transfusion; 1995; 35(11):903-10. PubMed ID: 8604486
[TBL] [Abstract][Full Text] [Related]
15. The association of elevated alanine aminotransferase levels with hepatitis E virus infections among blood donors in China.
Wang M; He M; Wu B; Ke L; Han T; Wang J; Shan H; Ness P; Guo N; Liu Y; Nelson KE
Transfusion; 2017 Feb; 57(2):273-279. PubMed ID: 28194856
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre.
Desassis JF; Laperche S; Girault A; Kolko A; Bouchardeau F; Zins B; Poignet JL; Couroucé AM
Nephrol Dial Transplant; 1999 Nov; 14(11):2692-7. PubMed ID: 10534514
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinical significance of SEN virus infection among volunteer blood donors in southern Taiwan.
Dai CY; Yu ML; Lin ZY; Chen SC; Hsieh MY; Wang LY; Tsai JF; Chuang WL; Chan WY
Dig Dis Sci; 2004 Aug; 49(7-8):1181-5. PubMed ID: 15387343
[TBL] [Abstract][Full Text] [Related]
18. GBV-C/HGV infection in end-stage renal disease: a serological and virological survey.
Fabrizi F; Lunghi G; Pozzi C; Colzani S; Tentori F; Del Vecchio L; Corti M; Pagano A; Locatelli F
J Nephrol; 2000; 13(1):68-74. PubMed ID: 10720218
[TBL] [Abstract][Full Text] [Related]
19. Unidentified virus-like particles are detected in plasmas with elevated ALT levels: are they significant of etiological agent(s) of non-B, non-C hepatitis?
Kaito M; Tanaka H; Horiike S; Fujita N; Iwasa M; Kobayashi Y; Gabazza EC; Adachi Y; Konishi M; Watanabe S
Med Mol Morphol; 2007 Mar; 40(1):23-8. PubMed ID: 17384986
[TBL] [Abstract][Full Text] [Related]
20. The serological and molecular epidemiology of GB virus C/hepatitis G virus infection in a hepatitis C and B endemic area.
Yu ML; Chuang WL; Dai CY; Lu SN; Wang JH; Huang JF; Chen SC; Lin ZY; Hsieh MY; Tsai JF; Wang LY; Chang WY
J Infect; 2001 Jan; 42(1):61-6. PubMed ID: 11243756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
